BRPI0820430A2 - Composto - Google Patents

Composto

Info

Publication number: BRPI0820430A2
Authority: BR; Brazil
Prior art keywords: compound
Prior art date: 2007-11-19

Application number

BRPI0820430-6A

Other languages

English (en)

Inventor

Salah Chettibi

Ben Newton

Magne Solbakken

Original Assignee

Ge Healthcare Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-11-19

Filing date

2008-11-19

Publication date

2015-05-26

2008-11-19 Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd

2015-05-26 Publication of BRPI0820430A2 publication Critical patent/BRPI0820430A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/082—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being a RGD-containing peptide

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Radiology & Medical Imaging (AREA)
Physics & Mathematics (AREA)
Optics & Photonics (AREA)
Pharmacology & Pharmacy (AREA)
Pathology (AREA)
Gastroenterology & Hepatology (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Toxicology (AREA)
Engineering & Computer Science (AREA)
Urology & Nephrology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

BRPI0820430-6A 2007-11-19 2008-11-19 Composto BRPI0820430A2 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US98884007P	2007-11-19	2007-11-19
GB0722650A GB0722650D0 (en)	2007-11-19	2007-11-19	Novel imaging method
PCT/EP2008/065824 WO2009071444A2 (en)	2007-11-19	2008-11-19	Novel imaging method

Publications (1)

Publication Number	Publication Date
BRPI0820430A2 true BRPI0820430A2 (pt)	2015-05-26

Family

ID=38896533

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0820430-6A BRPI0820430A2 (pt)	2007-11-19	2008-11-19	Composto

Country Status (8)

Country	Link
US (1)	US8834843B2 (pt)
EP (1)	EP2219681A2 (pt)
JP (1)	JP5709522B2 (pt)
CN (1)	CN101951964B (pt)
BR (1)	BRPI0820430A2 (pt)
GB (1)	GB0722650D0 (pt)
RU (1)	RU2505316C2 (pt)
WO (1)	WO2009071444A2 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2571486C1 (ru) *	2014-11-05	2015-12-20	Общество с ограниченной ответственностью "ДИАМЕД"	Способ визуализации воспалений
EP3967704A4 (en) *	2019-06-11	2022-08-31	FUJIFILM Corporation	CYCLIC PEPTIDE, CELLULAR SCAFFOLDING MATERIAL, CELL SEPARATION MATERIAL AND CULTURE MEDIUM

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2452923C (en) *	2001-07-10	2012-02-07	Amersham Health As	Peptide-based compounds for targeting integrin receptors
US20040223912A1 (en) *	2003-05-07	2004-11-11	Montalto Michael Christopher	Compositions and methods for non-invasive imaging of soluble beta-amyloid
GB0317815D0 (en) *	2003-07-30	2003-09-03	Amersham Health As	Imaging agents
WO2005039547A1 (en) *	2003-10-01	2005-05-06	Merck Patent Gmbh	Alfavbeta3 and alfavbeta6 integrin antagonists as antifibrotic agents
EP1814598B1 (en) *	2004-11-22	2011-01-12	Ge Healthcare As	Contrast agents to target extracellular matrix
WO2006073314A1 (en)	2005-01-06	2006-07-13	Ge Healthcare As	Optical imaging
US20080206151A1 (en)	2005-04-25	2008-08-28	Alan Cuthbertson	Liposomes
AU2006292203A1 (en) *	2005-09-21	2007-03-29	Dask Technologies, Llc	Methods and compositions for organ and tissue functionality
GB0524987D0 (en) *	2005-12-08	2006-01-18	Ge Healthcare Ltd	Novel imaging agents for fibrosis
US20100069609A1 (en)	2006-06-21	2010-03-18	Erik Arstad	Chemical methods and apparatus

2007
- 2007-11-19 GB GB0722650A patent/GB0722650D0/en not_active Ceased
2008
- 2008-11-19 WO PCT/EP2008/065824 patent/WO2009071444A2/en active Application Filing
- 2008-11-19 US US12/742,984 patent/US8834843B2/en not_active Expired - Fee Related
- 2008-11-19 RU RU2010119187/15A patent/RU2505316C2/ru not_active IP Right Cessation
- 2008-11-19 JP JP2010534461A patent/JP5709522B2/ja not_active Expired - Fee Related
- 2008-11-19 BR BRPI0820430-6A patent/BRPI0820430A2/pt not_active IP Right Cessation
- 2008-11-19 CN CN200880117542.XA patent/CN101951964B/zh not_active Expired - Fee Related
- 2008-11-19 EP EP08856281A patent/EP2219681A2/en not_active Withdrawn

Also Published As

Publication number	Publication date
CN101951964A (zh)	2011-01-19
RU2505316C2 (ru)	2014-01-27
US20100316565A1 (en)	2010-12-16
US8834843B2 (en)	2014-09-16
JP5709522B2 (ja)	2015-04-30
WO2009071444A2 (en)	2009-06-11
WO2009071444A9 (en)	2009-10-01
GB0722650D0 (en)	2007-12-27
CN101951964B (zh)	2013-05-29
JP2011506273A (ja)	2011-03-03
EP2219681A2 (en)	2010-08-25
RU2010119187A (ru)	2011-12-27
WO2009071444A3 (en)	2009-12-23

Publication	Publication Date	Title
BRPI0813500A2 (pt)	2015-01-06	Compostos antivirais
BRPI0821086A2 (pt)	2014-10-07	Compostos inseticidas
DK2185567T3 (da)	2011-05-16	Substituerede bicyclolactam-forbindelser
ATE542825T1 (de)	2012-02-15	Substituierte piperidino-dihydrothienopyrimidine
EP2164799A4 (en)	2015-02-18	DOSING DISTRIBUTION CONTAINERS WITH COMBINATION UNIT
BRPI0811264A2 (pt)	2014-11-04	Compostos
EP1985620A4 (en)	2012-08-15	COMPOUND 10a-AZALIDE
BRPI0814519A2 (pt)	2014-09-30	Organopolissiloxano
BRPI0814424A2 (pt)	2015-01-06	Compostos heterociclila
EP2211752A4 (en)	2013-10-02	biopulp
BRPI0809996A2 (pt)	2014-10-14	Compostos
BRPI0923592A2 (pt)	2016-01-26	composto
EP2221301A4 (en)	2011-09-21	HETEROARYLOXY QUINAZOLINE DERIVATIVE
BRPI0815181A2 (pt)	2015-03-31	Compostos
DE112008003094A5 (de)	2010-08-12	Geomatte
DE602008001674D1 (de)	2010-08-19	Wimpernwickler
EP2182216A4 (en)	2015-10-28	COMPRESSOR WITH ONE SCREW
BRPI0814613A2 (pt)	2015-01-27	Compostos
DK2219566T3 (da)	2013-10-21	Ortoseled
BRPI0913805A2 (pt)	2016-11-01	composto
EP2204365A4 (en)	2012-02-22	ALKYLSULFONE DERIVATIVE
BRPI0820430A2 (pt)	2015-05-26	Composto
FIU20080334U0 (fi)	2008-10-22	Nostosiirtokuljetusväline
DE112008002909A5 (de)	2010-07-29	Verwahrbehältnis
ES1066408Y (es)	2008-04-16	Biberon monouso

Legal Events

Date	Code	Title	Description
2015-12-01	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 7A ANUIDADE.
2016-04-05	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.